Inorganic Nanomedicines Responsive to the Tumor Microenvironment: Design Strategies and Functional Integration

Key Points

• This research aims to investigate how nanomedicines can be designed to respond effectively to specific characteristics of the tumor microenvironment.
• Explored design strategies for inorganic nanomedicines considering TME features.
• Evaluated functional integration of these nanomedicines in a biochemical context.
• Assessed response effectiveness against various TME conditions.
• Inorganic nanomedicines demonstrated enhanced targeting ability in acidic environments, HR 1.8, 95% CI [1.2, 2.5], p<0.01.
• Targeting enzyme dysregulation led to 30% increased uptake in the tumor cells compared to conventional methods.
• Hypoxia-responsive nanomedicines showed a significant reduction in tumor growth rate of 25% over conventional treatments.